Bristol-Myers Squibb Company trailing returns
Bristol-Myers Squibb Company's 10-year return is +5.5% a year (CAGR) (+71.3% cumulative). How Bristol-Myers Squibb Company (BMY) has performed over the last day, week, month and year, over 5, 10, 20 and 30 years, and since inception, through October 16, 2026 — price return and dividends side by side, with the worst drop inside each window.
Trailing returns by period#
To 2026-10-16. Price return + dividends = total return. Per year (CAGR) for windows of a year or more, with the cumulative total return beneath. Worst drop: the deepest fall in the price from a high inside the window, and when it bottomed.
| Period | Price | DivsDividends | Total | Worst drop |
|---|---|---|---|---|
| 1 day | -1.4% | +0.0% | -1.4% | — |
| 5 days | +1.1% | +0.0% | +1.1% | -4.1%Oct 13 |
| 1 month | -6.1% | +1.0% | -5.1% | -11.3%Oct 13 |
| YTD | +10.8% | +4.9% | +15.7% | -16.8%Oct 13 |
| 1 year | +37.7% | +6.1% | +43.8% | -16.8%Oct 2026 |
| 5 years | +0.5% | +4.2% | +4.7%+25.9% | -51.1%Jul 2024 |
| 10 years | +1.8% | +3.7% | +5.5%+71.3% | -51.1%Jul 2024 |
| 20 years | +4.6% | +4.0% | +8.6%+417.2% | -51.1%Jul 2024 |
| 30 years | +3.1% | +3.6% | +6.7%+598.7% | -76.7%Oct 2008 |
| Since inception (1972) | +6.6% | +2.3% | +8.8%+9931.9% | -76.7%Oct 2008 |
Growth of BMY#
Actual level with dividends reinvested (solid); dashed lines are each window's constant-rate path from start to today.
- 5 years+4.7%/year · +25.9%
- 10 years+5.5%/year · +71.3%
- 20 years+8.6%/year · +417.2%
- 30 years+6.7%/year · +598.7%
- Since inception (1972)+8.8%/year · +9931.9%
Methodology#
Trailing returns measure from the closest close about N years before the latest close (2026-10-16). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Price return is the change in BMY's closing price; total return reinvests dividends (from its split- and dividend-adjusted closes); the dividends column is the difference between the two. The worst drop is the largest fall in the closing price from a high to a later low inside the window, the way a drawdown is usually quoted. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Bristol-Myers Squibb Company's 10-year return?
- Over the last 10 years, Bristol-Myers Squibb Company (BMY) returned about +5.5% a year annualized (+71.3% cumulative total return).
- What is Bristol-Myers Squibb Company's 20-year annualized return?
- Over the last 20 years, Bristol-Myers Squibb Company (BMY) compounded at about +8.6% a year (+417.2% cumulative).
- What is Bristol-Myers Squibb Company's 30-year annualized return?
- Over the last 30 years, Bristol-Myers Squibb Company (BMY) compounded at about +6.7% a year (+598.7% cumulative).
- What is Bristol-Myers Squibb Company's return since inception?
- Since 1972, Bristol-Myers Squibb Company (BMY) has compounded at about +8.8% a year — +9931.9% in total.